GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Terce Laboratories Ltd (BOM:524314) » Definitions » E10

Gujarat Terce Laboratories (BOM:524314) E10 : ₹-0.81 (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Gujarat Terce Laboratories E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Gujarat Terce Laboratories's adjusted earnings per share data for the three months ended in Dec. 2023 was ₹0.910. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹-0.81 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-25), Gujarat Terce Laboratories's current stock price is ₹55.95. Gujarat Terce Laboratories's E10 for the quarter that ended in Dec. 2023 was ₹-0.81. Gujarat Terce Laboratories's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Gujarat Terce Laboratories was 53.76. The lowest was 0.00. And the median was 46.47.


Gujarat Terce Laboratories E10 Historical Data

The historical data trend for Gujarat Terce Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Terce Laboratories E10 Chart

Gujarat Terce Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.39 -0.38 -0.72

Gujarat Terce Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.80 -0.72 -0.87 -0.89 -0.81

Competitive Comparison of Gujarat Terce Laboratories's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Terce Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Terce Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Terce Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Gujarat Terce Laboratories's Shiller PE Ratio falls into.



Gujarat Terce Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Gujarat Terce Laboratories's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.91/152.9243*152.9243
=0.910

Current CPI (Dec. 2023) = 152.9243.

Gujarat Terce Laboratories Quarterly Data

per share eps CPI Adj_EPS
201403 0.224 91.425 0.375
201406 -0.072 94.103 -0.117
201409 0.100 96.780 0.158
201412 0.030 96.780 0.047
201503 0.003 97.163 0.005
201506 -1.387 99.841 -2.124
201509 -0.311 101.753 -0.467
201512 -0.490 102.901 -0.728
201603 1.283 102.518 1.914
201606 -1.250 105.961 -1.804
201609 1.430 105.961 2.064
201612 0.052 105.196 0.076
201703 -0.645 105.196 -0.938
201706 -1.779 107.109 -2.540
201709 1.530 109.021 2.146
201712 0.490 109.404 0.685
201803 0.116 109.786 0.162
201806 -0.806 111.317 -1.107
201809 0.010 115.142 0.013
201812 0.770 115.142 1.023
201903 0.480 118.202 0.621
201906 -1.641 120.880 -2.076
201909 0.230 123.175 0.286
201912 0.500 126.235 0.606
202003 -0.770 124.705 -0.944
202006 -0.598 127.000 -0.720
202009 -0.021 130.118 -0.025
202012 -0.100 130.889 -0.117
202103 -2.680 131.771 -3.110
202106 2.160 134.084 2.464
202109 0.610 135.847 0.687
202112 0.640 138.161 0.708
202203 -2.230 138.822 -2.457
202206 -2.540 142.347 -2.729
202209 -0.790 144.661 -0.835
202212 -0.004 145.763 -0.004
202303 1.090 146.865 1.135
202306 -1.760 150.280 -1.791
202309 0.450 151.492 0.454
202312 0.910 152.924 0.910

Add all the adjusted EPS together and divide 10 will get our e10.


Gujarat Terce Laboratories  (BOM:524314) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Gujarat Terce Laboratories was 53.76. The lowest was 0.00. And the median was 46.47.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Gujarat Terce Laboratories E10 Related Terms

Thank you for viewing the detailed overview of Gujarat Terce Laboratories's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Gujarat Terce Laboratories (BOM:524314) Business Description

Traded in Other Exchanges
N/A
Address
Near Shivalik High-Street,, D/801 & 802,The First,, Behind Keshavbaug Party Plot,, Vastrapur,, Ahmedabad, GJ, IND, 380015
Gujarat Terce Laboratories Ltd is an India company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, and syrup and injection. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash , Aziter and others.

Gujarat Terce Laboratories (BOM:524314) Headlines

No Headlines